07/21/2021: Lab Alert: Changes to CDC RT-PCR for SARS-CoV-2 Testing
After December 31, 2021, CDC will withdraw the request to the U.S. Food and Drug Administration (FDA) for Emergency Use Authorization (EUA) of the CDC 2019-Novel Coronavirus (2019-nCoV) Real-Time RT-PCR Diagnostic Panel, the assay first introduced in February 2020 for detection of SARS-CoV-2 only. CDC is providing this advance notice for clinical laboratories to have adequate time to select and implement one of the many FDA-authorized alternatives.
In preparation for this change, CDC recommends clinical laboratories and testing sites that have been using the CDC 2019-nCoV RT-PCR assay select and begin their transition to another FDA-authorized COVID-19 test. CDC encourages laboratories to consider adoption of a multiplexed method that can facilitate detection and differentiation of SARS-CoV-2 and influenza viruses. Such assays can facilitate continued testing for both influenza and SARS-CoV-2 and can save both time and resources as we head into influenza season.
This is what the creator of the PCR test, as well as many medical professionals, have been saying for a long time, that the PCR test is not designed for this purpose.
Is this why the Flu seemed to all but disappear over the last year?
Is this why the COVID-19 numbers were similar to the Flu numbers of previous years?
Since the whole COVID narrative was based on faulty testing, does this mean that everything that has happened over the last year is based on faulty data???
Source: CDC, https://www.cdc.gov/csels/dls/locs/2021/07-21-2021-lab-alert-Changes_CDC_RT-PCR_SARS-CoV-2_Testing_1.html